Hemab Therapeutics Holdings, Inc. (COAG) fundamentals chart
COAGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026
$39.15+0.09 (+0.23%)
Close on Nov 18, 2026Market cap $1.83BP/E –Yield –
Fundamental chart
No history to chart yet
This company has fewer than two fiscal years of reported financials.
See a number that looks wrong?